MedTrace Logo

Neurodevelopmental Outcomes and Fluconazole Prophylaxis

NCT00975949 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2013-01-15

No results posted yet for this study

Summary

The purpose of this study is to compare the neurodevelopmental outcome and quality of life between the fluconazole-treated and the placebo-treated patients that were enrolled in a fluconazole prophylaxis study that occurred in the investigators' neonatal intensive care unit (NICU) between 1998-2000.

Conditions

  • Neurodevelopmental Outcomes

Interventions

OTHER

Survey

Parents of subjects were interviewed and two surveys were obtained, the Child Health Questionnaire and the Vineland-II.

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • David Kaufman, MD · University of Virginia

Eligibility

Min Age
7 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-10-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00975949 on ClinicalTrials.gov